Related Experiment Video
Updated: Aug 13, 2026
13:08
Processing of Human Reduction Mammoplasty and Mastectomy Tissues for Cell Culture
Published on: January 3, 2013
Anticlastogenicity in cultured mammalian cells
1Institute of Human Genetics, University of Erlangen-Nürnberg, Germany.
Mutation Research
|June 1, 1992
Summary
Anticlastogenicity research reveals mechanisms of chromosomal aberration and aids in protecting individuals. Studies using human cells show anticlastogens (ACs) can be categorized by their effects on different genetic changes.
Area of Science:
- Cytogenetics
- Environmental Mutagenesis
- Cancer Research
Background:
- Chromosomal anomalies are fundamental to oncogenesis.
- Research on anticlastogenicity provides insights into protecting individuals from environmental mutagens.
- Human cell studies on anticlastogenicity began in 1969/70.
Purpose of the Study:
- To elucidate mechanisms of anticlastogenicity.
- To explore practical applications of anticlastogenicity for risk protection.
- To categorize anticlastogens (ACs) based on their effects on cytogenetic endpoints.
Main Methods:
- Utilizing human and mammalian cell systems.
- Examining various application modes for clastogens and anticlastogens (ACs), with simultaneous addition being favored.
- Analyzing a spectrum of cytogenetic endpoints, including chromosomal breaks, rearrangements, and sister chromatid exchanges (SCEs).
Main Results:
- AC efficacy varies across different cytogenetic changes (breaks, rearrangements, SCEs).
- ACs can be categorized based on their influence on cytogenetic endpoints, relevant to oncogenic potential.
- Factors like application timing, cell type, and clastogen mechanism significantly influence AC action.
- S9 mix addition can alter AC efficacy patterns.
Conclusions:
- Anticlastogenicity research offers valuable mechanistic and protective insights.
- Understanding AC categorization is crucial for assessing oncogenic potential.
- Combined AC application does not appear to potentiate or add to individual effects.
